Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), bought 9,585 shares at $3.71 ($15K) on 2010-05-07, disclosed to the SEC on 2010-05-11.
Open-market purchase of $15k ARRY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,585 | $0 | 0.0% |
| 2 | $3.71 | 4,000 | $15K | 100.0% |
| Total | $1.55 avg | 9,585 | $15K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |